Audiologists in Silver Spring, MD Accepting Medicare

28 Audiologists found. Showing 21 - 28

Richard H. Israel, PHD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2101 Medical Park Dr, Suite 211, Silver Spring, MD 20902 Phone: 301-589-3277    Fax: 301-589-3632

Mr. Jeff A Zolt, MA CCCA Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1734 Elton Rd, Suite 104, Silver Spring, MD 20903 Phone: 301-434-4300    Fax: 301-434-6299

Hearing Health Md Llc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2101 Medical Park Dr, #211, Silver Spring, MD 20902 Phone: 301-589-3277    Fax: 301-589-3632

Candice Evita Ortiz-hawkins, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 11886 Healing Way Ste 530, Silver Spring, MD 20904 Phone: 240-670-1200    Fax: 240-719-0534

Patricia Randolph, Ph.d., Ccc-a Audiologist Medicare: Not Enrolled in Medicare Practice Location: 11120 New Hampshire Ave, Suite 504, Silver Spring, MD 20904 Phone: 301-593-3200    Fax: 301-593-3900

Hearing Healthcare, Inc. Audiologist Medicare: Medicare Enrolled Practice Location: 3913 Ferrara Dr, Silver Spring, MD 20906 Phone: 301-946-2434    Fax: 301-946-2435

Dr. Ashley Stavish, AU,D, Audiologist Medicare: Accepting Medicare Assignments Practice Location: 10801 Lockwood Dr Ste 360, Silver Spring, MD 20901 Phone: 301-593-5200    Fax: 301-593-7835

Venita Dzime-assison Audiologist Medicare: Not Enrolled in Medicare Practice Location: 14304 Layhill Valley Ct, Silver Spring, MD 20906 Phone: 202-651-5018

News Archive

Mild pulses of electrical energy just as effective as more powerful and painful shocks to interrupt life-threatening rapid heartbeats

Ventricular tachycardia (VT) is a fast heartbeat originating in the heart's ventricle chamber and can be life-threatening. VT is often treated with an implantable cardioverter-defibrillator (ICD), a device that delivers an electrical shock to restore an irregular heart rhythm.

Novel coronavirus mutation could spell trouble for vaccine development

New research shows that the novel coronavirus is undergoing mutations that could make it challenging to develop a vaccine against. There are a few vaccine candidates that are in the making to prevent COVID-19. With a potential for mutation, the vaccines that are being developed now may not work against the emergent mutated strains worry Taiwanese and Australian researchers. The study is titled, "Analysis of the mutation dynamics of SARS-CoV-2 reveals the spread history and emergence of 2 RBD mutant with lower ACE2 binding affinity."

New method reveals complete set of aberrant signaling pathways that give rise to cancers

One major obstacle in the fight against cancer is that anticancer drugs often affect normal cells in addition to tumor cells, resulting in significant side effects. Yet research into development of less harmful treatments geared toward the targeting of specific cancer-causing mechanisms is hampered by lack of knowledge of the molecular pathways that drive cancers in individual patients.

United Therapeutics announces FDA approval of dinutuximab for treatment of high-risk neuroblastoma

United Therapeutics Corporation announced today that the United States Food and Drug Administration has approved Unituxin (dinutuximab) Injection (formerly called ch14.18), in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), and 13-cis-retinoic acid (RA), for the treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to prior first-line multiagent, multimodality therapy.

Read more Medical News

› Verified 9 days ago

• 1
• 2(current)